StockPreacher.com Issues Trading Outlook for MDRNA Inc.

• Press Release
• Source: StockPreacher
• On 6:50 am EDT, Wednesday October 14, 2009

DALLAS, Oct. 14, 2009 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring biopharmaceutical company MDRNA Inc. (Nasdaq:MRNA - News). The report includes financial and investment analysis, analyst consensus, and pertinent industry information you need to know to make an educated investment decision.

Related Quotes

Symbol	Price	Change
AMGN	55.38	0.00

{"s" : "amgn,biib,emis.ob,jnj,mrna","k" : "c10,l10,p20,t10","o" : "","j" : ""}

The investment report on MDRNA Inc. (Nasdaq:MRNA - News) should be of particular interest to comparable companies: Amgen Inc. (Nasdaq:AMGN - News), Biogen Idec Inc. (Nasdaq:BIIB - News), Emisphere Technologies Inc. (OTCBB:EMIS - News) and Johnson & Johnson (NYSE:JNJ - News).

The full report is available at: http://www.stockpreacher.com/n/MRNA

Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/StockPreacher

MDRNA Inc. (MRNA) is a biotechnology company focused on the discovery, development and commercialization of pharmaceuticals based on RNA interference (RNAi). The Company's infrastructure provides for pre-clinical scale manufacturing of both siRNAs and delivery materials, the comprehensive analysis and optimization of these compounds both individually and as drug candidates, and the filing of Investigational New Drug Applications. The Company develops RNAi-based product candidates for the treatment of cancer, metabolic disorders, inflammation and viral infections. MRNA's various development programs comprise: oncology, metabolic disorders and inflammation.

Message Board Search for GNTB: http://www.boardcentral.com/boards/MRNA

In the report, the analyst notes:

"MRNA recently announced that it received a letter from The NASDAQ Stock Market LLC notifying the Company that it has regained full compliance with all requirements for remaining on The NASDAQ Global Market, specifically NASDAQ Marketplace Rule 5450(b)(2) (the "market value standard"), which requires, among other things, a minimum market value of listed securities of $50.0 million (NASDAQ Marketplace Rule 5450(b)(2)(A))."

"The majority of analysts believe that MRNA's current resources are sufficient to fund its planned operations to approximately year-end 2009. This estimate is based on the Company's ability to perform planned R&D activities and the receipt of planned funding. Volatility in its stock price, as well as global market conditions, could make it difficult for the Company to raise capital on favorable terms, or at all. Any financing MRNA obtains may further dilute or otherwise impair the ownership interest of its current stockholders. ...These factors, among others, raise substantial doubt about MRNA's ability to continue as a going concern both in the distant and near future."

To read the entire report visit: http://www.stockpreacher.com/n/MRNA

StockPreacher.com is a small-cap research and investment commentary provider. StockPreacher.com strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on StockPreacher, please visit: http://www.stockpreacher.com

StockPreacher.com Disclosure

StockPreacher.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. StockPreacher.com is a Web site wholly-owned by BlueWave Advisors, LLC. Please read our report and visit our Web site, StockPreacher.com, for complete risks and disclosures.

StockPreacher.com
Jeff Bishop
(469)-252-3505
press@beaconequity.com